Print

GlaxoSmithKline (GSK) Says 5 Late-Stage Flu Trials Met Goals  
10/22/2012 7:47:02 AM

GlaxoSmithKline Plc said results from five late-stage trials of two experimental quadrivalent influenza vaccines (QIV) met the main goal of protecting against mild as well as moderate-severe cases of influenza.
//-->